• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9.

PCSK9 encodes proprotein convertase subtilisin/kexin type 9a (PCSK9), a member of the proteinase K subfamily of subtilases. Missense mutations in PCSK9 cause an autosomal dominant form of hypercholesterolemia in humans, likely due to a gain-of-function mechanism because overexpression of either WT or mutant PCSK9 reduces hepatic LDL receptor protein (LDLR) in mice. Here, we show that livers of knockout mice lacking PCSK9 manifest increased LDLR protein but not mRNA. Increased LDLR protein led to increased clearance of circulating lipoproteins and decreased plasma cholesterol levels (46 mg/dl in Pcsk9(-/-) mice versus 96 mg/dl in WT mice). Statins, a class of drugs that inhibit cholesterol synthesis, increase expression of sterol regulatory element-binding protein-2 (SREBP-2), a transcription factor that activates both the Ldlr and Pcsk9 genes. Statin administration to Pcsk9(-/-) mice produced an exaggerated increase in LDLRs in liver and enhanced LDL clearance from plasma. These data demonstrate that PCSK9 regulates the amount of LDLR protein in liver and suggest that inhibitors of PCSK9 may act synergistically with statins to enhance LDLRs and reduce plasma cholesterol.

Pubmed ID: 15805190

Authors

  • Rashid S
  • Curtis DE
  • Garuti R
  • Anderson NN
  • Bashmakov Y
  • Ho YK
  • Hammer RE
  • Moon YA
  • Horton JD

Journal

Proceedings of the National Academy of Sciences of the United States of America

Publication Data

April 12, 2005

Associated Grants

  • Agency: NHLBI NIH HHS, Id: HL 20948
  • Agency: NHLBI NIH HHS, Id: HL 38049

Mesh Terms

  • Animal Feed
  • Animals
  • Apolipoproteins B
  • Cells, Cultured
  • Cholesterol
  • Drug Synergism
  • Electrophoresis, Polyacrylamide Gel
  • Female
  • Gene Deletion
  • Hepatocytes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Liver
  • Lovastatin
  • Male
  • Mice
  • Mice, Knockout
  • Phenotype
  • Proprotein Convertases
  • RNA, Messenger
  • Receptors, LDL
  • Serine Endopeptidases